Drug shortage: Promethazine Hydrochloride Injection (PHENERGAN, PROMETHAZINE HYDROCHLORIDE)
FDA lists 10 presentations as Current. Availability: Unavailable (5), Available (5). Reason: Other; Demand increase for the drug. Companies: Hikma Pharmaceuticals USA, Inc., XGen Pharmaceuticals DJB, Inc..
- Published by source
- 2023-11-21
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Products
- Promethazine Hydrochloride Injection PHENERGAN PROMETHAZINE HYDROCHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD
- Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-11-21
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #904 | new | 2026-10-22 | 70a5f1bc656a…796352 | 5a52386cdd5a…ea0374 |
| #1221 | update | 2026-10-23 | f89da68ed80a…926245 | a84f217aae13…03db13 |
Chain head: #1250 0c9a4a81d7d8…29590d